Guo H, Wang B, Li H, et al
CV: cardio-vascular EMA: European Medicines Agency FDA: Food and Drugs Administration GLP-1 RA: glucagon-like peptide 1 receptor agonist HbA1c: glycated haemoglobin HR: hazard ratio MACE: major adverse cardiovascular events NAFLD: non-alcoholic fatty liver disease NASH: non-alcoholic steatohepatitis T2D: type 2 diabetes The authors gratefully acknowledge Professor Giuliana Arcidiacono, English and Anglo-American language PhD, University of Catania, for the language revision of the manuscript
Classification and differential diagnosis of diabetic nephropathy
Some people shouldnt take semaglutide, like those with a history of thyroid cancer or people who are pregnant or breastfeeding
But then Novo made a higher unsolicited offer, launching a bidding war
Understanding these predispositions can support a more personalized conversation with your provider about whether your individual biology aligns with lifestyle-first approaches or whether pharmacologic support may complement your efforts effectively